DDMAC warning and untitled letters in 2008 total 21

Share this article:

The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 – scarcely more than the 20 letters the unit sent out in 2007.

As in 2007, 10 were “warning letters,” the remainder being of the somewhat less serious “untitled” variety.

In 2006, DDMAC issued 22 letters reprimanding drug manufacturers for promotional materials deemed violative of the Food, Drug and Cosmetics Act, typically for overstating efficacy and/or underplaying risks, but 14 of those were warning letters.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.